|
Intrauterine adhesionsTrauma to and/or infection of the uterine lining (endometrium) may lead to the formation of intrauterine adhesions or destruction of the endometrial lining. Intrauterine adhesions are defined as scar tissue inside the uterine cavity. CausesThe principle cause of intrauterine adhesions is trauma to the uterine cavity. This may occur following dilation and curettage (D & C), an outpatient surgical procedure during which the cervix is dilated and the tissue contents of the uterus are emptied. D & C may be performed for excess uterine bleeding after childbirth, pregnancy termination, or other gynecological conditions. Less commonly, prolonged use of an intrauterine device (IUD), infections of the endometrium (endometritis), and surgical procedures involving the uterus (such as removal of fibroids) may also lead to the development of intrauterine adhesions. SymptomsWomen with intrauterine adhesions may have no obvious problems. Many patients, however, may DiagnosisHysterosalpingography (HSG), an x-ray procedure, is a common method used to diagnose intrauterine adhesions. During an HSG, a solution is injected into the uterus to illustrate the inner shape of the uterus and determine if the fallopian tubes are open. Hysteroscopy is also used to diagnose intrauterine adhesions. This is a procedure in which a thin, telescope-like instrument is inserted through the cervix to allow direct visualization of the uterine cavity. Although HSG is a useful screening test, hysteroscopy is the most accurate method of evaluating intrauterine adhesions. Both HSG and hysteroscopy can be performed in an office setting without general anesthesia. Treatment Surgical removal of intrauterine adhesions with hysteroscopic guidance is generally recommended.
Following removal of the adhesions, many surgeons recommend temporarily placing a device, such as a plastic
catheter, inside the uterus in an effort to keep the walls of the uterus apart and prevent adhesions from reforming. Reproductive Outcome Reproductive outcome appears to correlate with the type and extent of the adhesions.
After treatment, patients with mild to moderate adhesions have full-term pregnancy rates of approximately 70 to 80
percent, and menstrual dysfunction is frequently alleviated. Alternatively, patients with severe adhesions or extensive Content Provided By: |